Frontlight ResearchEarly access
Trial site
Beijing You'an Hospital, Capital Medical University
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Hepatitis B7 trials
- Liver and biliary tract cancer5 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Liver cirrhosis2 trials
- COPD1 trial
- High blood pressure1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Not yet recruiting7 trials
- Active, not recruiting3 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Peking University First Hospital2 trials
- Beijing Continent Pharmaceutical Co, Ltd.1 trial
- Beijing Friendship Hospital1 trial
- Beijing YouAn Hospital1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- and 8 more
Running trials
Not yet recruiting
Enrolling by invitation
Recruiting
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hepatitis B4 recruiting
- Liver and biliary tract cancer3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis2 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Completed
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Site data: ClinicalTrials.govUpdated 17 Nov 2026